Tumour suppressor genes may have a role in the control of trophoblast cell population expansion as trophoblast invasion occurs. To investigate this hypothesis, the location of tumour suppressor gene and protooncogene products were studied at various stages of trophoblast differentiation and invasion. Trophoblast and decidua were obtained from eight women having a therapeutic termination of pregnancy. Immunohistochemistry was used to localize the products of c-myc, c-erB-2, RB, BCL-2, P21, and P53 genes and anticytokeratin was used to identify fetal cells amongst the maternal decidual cells. The most differentiated and furthest invading trophoblast cell type, the multinucleated trophoblast, expressed a combination of genes which may indicate a high apoptotic rate. The other fully differentiated trophoblast, the syncytiotrophoblast, expressed BCL-2 suggesting protection from apoptosis. The co-occurrence of proto-oncogenes and the products of tumour suppressor genes in first trimester trophoblast suggests an important role not only in negative regulation of cellular invasion but also in population expansion through the presence of oncogenes and anti-apoptotic proteins.
Introduction
The term 'pseudo-malignancy' has been used to describe the properties of the early human placenta (Ohlsson et al., 1993) , and refers to the similarities between trophoblast and malignant cancer cells; namely invasiveness, high cellular proliferation rate, lack of cell contact inhibition and immune privilege. Tumour growth can be considered as the result of a balance between proliferation and cell death by necrosis or programmed cell death (apoptosis) (Arends, 1995) . Products of certain critical genes including c-myc, P53, c-erB-2, P21, RB, and BCL-2 regulate transit between states of growth arrest, rapid turnover of cells, apoptosis, and population expansion.
c-myc is part of the post-receptor intracellular signalling pathway for the stimulation of cell proliferation by a growth factor (Alberts et al., 1994) . Cells in which c-myc expression is switched on independently of growth factors undergo apoptosis (Alberts et al., 1994) . The c-erB-2 oncogene encodes a truncated form of the epidermal growth factor receptor. Cells expressing this oncogene behave as though they are constantly being signalled to proliferate by a growth factor (Alberts et al., 1994) . The product of the retinoblastoma tumour suppressor gene (RB) operates in the midst of the cell cycle clock apparatus (Weinberg, 1995) ; its main role is to act as a signal transducer connecting the cell cycle clock with the transcriptional machinery. P53 has been shown to induce apoptosis (YonishRouch et al., 1991) , while BCL-2 inhibits programmed cell death (Bagg and Cossman, 1993) . P21 inhibits the cell cycle, inhibits apoptosis, inhibits DNA synthesis and stimulates cell differentiation (Stinchcomb, 1995) .
Individually, the expression of c-myc, c-erB-2, RB, BCL-2, P21, and P53, has been demonstrated in first trimester placenta (Olhsson and Pfeifer-Ohlsson, 1986; Diebold et al., 1991; Jokhi et al., 1994; Roncalli et al., 1994; Sakuragi et al., 1994; Kim et al., 1995; King et al., 1995; Marzusch et al., 1995; Stahlebackdhal et al., 1995) . In the first trimester of human pregnancy, the cytotrophoblast proliferates and invades deep into the maternal decidua under strict temporal and spatial control. Decreased proliferation, occurring as pregnancy proceeds into the second and third trimester (Hamilton et al., 1962) , is one method of controlling trophoblast cell invasion. Proto-oncogene and tumour suppresser gene product expression has been shown to be spatio-temporally regulated as placental development occurs (Pfeifer-Ohlsson et al., 1984; Olhsson and Pfeifer-Ohlsson, 1986; Roncalli et al., 1994) . Similarly, maternal expression of the proliferation stimulating protooncogenes c-fos and c-jun are down-regulated as pregnancy proceeds (Salmi et al., 1996) . Therefore, these proto-oncogenes and tumour suppresser genes may play a role in placental development as pregnancy proceeds.
In this study, gene products thought to control the balance between proliferation and apoptosis were studied at various stages of trophoblast differentiation in serial histopathological sections. This has enabled us to suggest that they may regulate trophoblast proliferation, cell death and invasion in the first trimester. Further evidence of the importance of these genes to the control of trophoblast invasion was sought by comparing their expression with the pattern of apoptotic cells as demonstrated by terminal deoxytransferase-mediated deoxyuridine 5Ј-triphosphate nick end labelling (TUNEL) labelling. 
Material and methods

Tissue preparation
First trimester placental tissue of gestational age 8-12 weeks was obtained following elective terminations of apparently normal pregnancy. Permission to use these tissues was granted by the Liverpool Ethics Committee. The specimens (n ϭ 8) were washed within 5 min in phosphate-buffered saline (PBS) and examined under a binocular dissecting microscope. Placentae that came from the implantation site were selected and fixed in freshly prepared 4% paraformaldehyde in 100 mM PBS (pH 7.2) at 4°C for 24 h.
Antibodies
Eight commercially available, mouse monoclonal antibodies were used in this study, as shown in Table I . Two negative controls were used, the primary antibody was replaced with Tris-buffered saline, (TBS) containing 0.1% bovine serum albumin (BSA) or with mouse immunoglobulin (Ig)G at the same concentration as the primary antibody.
Immunohistochemistry
After embedding in paraffin wax, 5 µm sections were cut and mounted on poly-L-lysine coated slides, air-dried and heated for 20 min at 60°C before dewaxing with xylene followed by rehydration. In order to maximize visualization of the gene product, each antibody was tested at a series of dilutions, with and without antigen retrieval and in the presence and absence of enhancement. Antigen retrieval conditions (pH of the buffer, heating intensity and time) were altered in order to ascertain optimal antigen detection with minimal background staining (Shi et al., 1997) . Optimization of immunohistochemical staining was achieved by pressure cooking the sections in citrate buffer (10 mM), pH 6.0, for 4 min at low pressure in an aluminium pressure cooker. Antigen retrieval did not enhance the staining for c-myc product. The antibody dilutions found to give optimal immunohistochemistry are shown in Table I . After dilution of the antibody in TBS containing 0.1% BSA, sections were incubated at room temperature for 60 min. The second antibody, a rabbit antimouse immunoglobulin (Dako Ltd, High Wycombe, Bucks, UK) was then applied at 1:50 dilution for 30 min at room temperature. This was followed by treatment with alkaline phosphatase anti-alkaline phosphatase (APAAP) complex (Dako Ltd.) at a 1:50 dilution for 30 min at room temperature. To enhance the intensity of the APAAP labelling reaction, the second and third incubation steps were repeated (each step for 30 min). For development of alkaline phosphatase, the new fuchsin method was employed (Dako Ltd), the substrate solution contained Tris-HCl, pH 8.8 (20 min at room temperature) and 0.2 mM 478 levamisole was used to inhibit endogenous alkaline phosphatase. The placental isoenzyme is heat labile and was destroyed during the embedding and antigen retrieval steps. Finally, sections were counterstained with haematoxylin for 20 s and mounted in Aquamount (BDH, Poole, UK).
TUNEL labelling
The Oncor Apoptag kit (Oncor, Gaithersburg, MD, USA) was used in accordance with the manufacturer's instructions to detect apoptotic cells by direct immunoperoxidase detection of digoxigenin-labelled genomic DNA.
All immunohistochemistry was repeated on two separate occasions to ensure the intensity and staining pattern was reproducible. Each slide was studied by three observers; one unblinded (SQ), one blinded to the gestation (GV) and one blinded to the antibody used and the gestation (CB). Each observer used a simple intensity scoring system whereby ϩ was weak staining, ϩϩ moderate staining and ϩϩϩ intense staining. The positive controls all showed intense staining with the antibody concerned. The scores on Table II are the average of all six evaluations.
Results
There was some variation in the staining intensity between specimens from different individuals. Each slide contained sections of decidua basalis, decidua parietalis and implantation site villi, so that the intensity of staining was compared within each specimen. No differences were seen in gene expression between the 8 and 12 week placentas studied.
Trophoblast cells were identified by their staining with anticytokeratin in neighbouring sections, intermediate trophoblast cells were cytokeratin-positive cells within the decidua. Endovascular trophoblast cells were identified as cytokeratin-positive cells within vessels in the superficial decidua basalis. Multinucleated trophoblast cells were cytokeratin-positive large cells within the decidua basalis that contained more than three (large round) nuclei.
The negative controls (performed by leaving out the primary antibody step), showed no staining at all with the APAAP and fucsidin red, indicating that endogenous alkaline phosphatase had been effectively destroyed. There was also no staining with the mouse IgG controls showed except at a dilution of 1:10 when a light background staining was observed. 
ϩ ϭ low intensity staining; ϩϩ ϭ moderate intensity staining; ϩϩϩ ϭ high intensity staining; Ϯ ϭ patchy staining; occ ϭ occasional staining one positive cell per villous.
c-myc product was demonstrated in the cytoplasm of the cytotrophoblast cell columns and multinucleated trophoblast. It was more prominent in the intermediate and endovascular trophoblast and very prominent in the syncytiotrophoblast (Figure 1a , negative control Figure 1b , Table II ). Staining for c-erB-2 product was more prominent in the distal end of the cytotrophoblast cell columns compared with the proximal end. Intermediate trophoblast, endovascular trophoblast, syncytial knots and multinculeated trophoblast all labelled clearly with anti-c-erB-2, but syncytiotrophoblast staining was patchy and tended to be stronger at the distal end of the villi nearest the cytotrophoblast cell columns (Figure 1c , Table II ). RB was observed in all types of trophoblast studied (Figure 1d ). BCL-2 staining was cytoplasmic and almost entirely confined to the syncytiotrophoblast and syncytial knots (Figure 1e , trophoblast identified with antibody to cytokeratin, Figure 1f) . The smaller cytotrophoblast cell columns stained with BCL-2, although larger columns did not. P21 was detected in the cytoplasm, and was most intensely demonstrated in the villous cytotrophoblast (Figure 1g ), but the intensity weakened with the depth of invasion so that the multinucleated trophoblast labelled only weakly. The P53 gene product was optimally seen when a high concentration (1:10) of the primary antibody was used. When mouse IgG was used at the same concentration weak cytoplasmic labelling occurs. Therefore only nuclear staining was counted as positive in this case. This positive observation was seen in approximately one cell per villous cross-section. TUNEL labelling was found to occur in patches, some villi contained many cells that were positive and others very few (Figure 1h) . Similarly with the extra villous trophoblast, in some areas nearly all the trophoblastic cells were TUNEL labelled and in other areas no trophoblast were positively labelled. No TUNEL labelling was seen on the negative controls.
Discussion
We have examined the immunolocalization of a number of tumour suppressor gene and proto-oncogene products to build up an overall picture of these closely interrelated genes in first trimester placental tissue. In contrast to a previous report (Ohlsson and Pfeifer-Ohlsson, 1986 ), c-myc product was found in the cytoplasm, rather than the nucleus. However cytoplasmic staining has been found in the first trimester (Diebold et al., 1991) , and in malignancies (Jack et al., 1986; Polacarz et al., 1989; Matsumura et al. 1990) . As expected, the c-erbB-2 product immunolocalized to trophoblast (Jokhi et al., 1994) and identified fetal cells amongst maternal decidual cells (King et al., 1995) . RB gene product was found in all types of trophoblast cells, in contrast to a previous study, where RB was not found in the syncytiotrophoblast (Roncalli et al., 1994) . However, these authors counted only nuclear staining as positive and, in this study, staining was cytoplasmic. Cytoplasmic RB immunolocalization has been recorded previously in the non-pregnant endometrium (Bukovsky et al., 1995) , and it therefore seems reasonable to assume it may have a function in this location in reproductive tissues. BCL-2 was immunolocalized to the syncytiotrophoblast, confirming previous findings (Sakuragi et al., 1994; Kim et al., 1995; Lea et al., 1997) . The P21 gene product has been found in normal term placental trophoblast but not in choriocarcinoma (Stahlebackdahl et al., 1995) . In this study, P21 was most abundant in immature trophoblast, consistent with its role in differentiation and the inhibition of apoptosis (Stinchcomb, 1995) . P53 staining was similar to that found previously (Roncalli et al., 1994; Marzusch et al., 1995) ; its immunolocalization probably represents physiological up-regulation of the P53 gene (Milner, 1991; Marzusch et al., 1995) .
Proto-oncogenes and tumour suppressor genes interact in a complex, only partially elucidated, way to control cellular proliferation, turnover, growth arrest and death (Arends, 1995) . Each type of trophoblast expressed a subtly different combination of genes. When these combinations were considered in the light of the present knowledge, it was the furthest invaded trophoblast cell type, the multinucleated trophoblast, that expressed the combination most likely to lead to apoptosis (c-myc, low P21, absent BCL-2 and RB). In comparison, the villous cytotrophoblast expressed gene products most likely to produce population expansion (high P21, only occasional cells expressed P53, absent BCL-2 and RB). The other fully differentiated trophoblast type, the syncytiotrophoblast, expressed BCL-2, suggesting protection from apoptosis. TUNEL labelling studies found patchy staining similar to that described by Uckan et al. (1997) , and were not helpful in determining which trophoblast cell morphology was undergoing the most apoptosis. Therefore, proto-oncogenes and tumour suppressor genes may contribute to the regulation and control of invasion by promoting apoptosis. Further evidence exists to support this conclusion. Fas ligand (FasL) is a membrane bound protein that induces apoptosis following interaction with Fas (Uckan et al., 1997) . FasL has been found in extravillous trophoblast in mice (Hunt et al., 1997) , trophoblast in humans (Uckan et al., 1997) and differentiating human cytotrophoblast in cell culture (Runic et al., 1996) .
The clinical importance of extravillous trophoblast differentiation was highlighted by Redline and Patterson (1995) , who found an increase in proliferative immature intermediate trophoblast in all placentas from women with pre-eclampsia. Defective trophoblast differentiation could also lead to other pregnancy complications, such as spontaneous miscarriage, growth retardation and placenta accreta. A recent report by Lea et al. (1997) has highlighted the importance of BCL-2 on the maintenance of pregnancy since the pregnancy from recurrent miscarriages patients demonstrated less intense BCL-2 staining in the villous syncytiotrophoblast.
